These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 7666203

  • 1. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis.
    Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA.
    J Neurosci; 1995 Sep; 15(9):6213-21. PubMed ID: 7666203
    [Abstract] [Full Text] [Related]

  • 2. Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain.
    Strada O, Hirsch EC, Javoy-Agid F, Lehéricy S, Ruberg M, Hauw JJ, Agid Y.
    J Neurosci; 1992 Dec; 12(12):4766-74. PubMed ID: 1464766
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL, Hunsaker JC, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR.
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [Abstract] [Full Text] [Related]

  • 8. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K, Kato T, Yohyama I, Nakamura S, Kameyama M.
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [Abstract] [Full Text] [Related]

  • 9. Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.
    Hu L, Côté SL, Cuello AC.
    Exp Neurol; 1997 Jan; 143(1):162-71. PubMed ID: 9000455
    [Abstract] [Full Text] [Related]

  • 10. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease.
    Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J.
    J Neurosci; 1993 Jun; 13(6):2540-50. PubMed ID: 8501520
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease.
    Kerwin JM, Morris CM, Perry RH, Perry EK.
    Neurosci Lett; 1992 Aug 31; 143(1-2):101-4. PubMed ID: 1436650
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
    DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, Cochran EJ, Kordower JH, Mufson EJ.
    Ann Neurol; 2002 Feb 31; 51(2):145-55. PubMed ID: 11835370
    [Abstract] [Full Text] [Related]

  • 13. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI.
    J Comp Neurol; 1999 Sep 06; 411(4):693-704. PubMed ID: 10421878
    [Abstract] [Full Text] [Related]

  • 14. Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia.
    Ichimiya Y, Arai H, Kosaka K, Iizuka R.
    Acta Neuropathol; 1986 Sep 06; 70(2):112-6. PubMed ID: 3739621
    [Abstract] [Full Text] [Related]

  • 15. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.
    Boissière F, Hunot S, Faucheux B, Hersh LB, Agid Y, Hirsch EC.
    Dement Geriatr Cogn Disord; 1997 Sep 06; 8(1):1-8. PubMed ID: 8997546
    [Abstract] [Full Text] [Related]

  • 16. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.
    Hock C, Heese K, Hulette C, Rosenberg C, Otten U.
    Arch Neurol; 2000 Jun 06; 57(6):846-51. PubMed ID: 10867782
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats.
    Parikh V, Khan MM, Terry A, Mahadik SP.
    J Psychiatr Res; 2004 Jun 06; 38(5):521-9. PubMed ID: 15380403
    [Abstract] [Full Text] [Related]

  • 18. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.
    Mufson EJ, Ikonomovic MD, Styren SD, Counts SE, Wuu J, Leurgans S, Bennett DA, Cochran EJ, DeKosky ST.
    Arch Neurol; 2003 Aug 06; 60(8):1143-8. PubMed ID: 12925373
    [Abstract] [Full Text] [Related]

  • 19. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C.
    Exp Neurol; 2005 Oct 06; 195(2):484-96. PubMed ID: 16085017
    [Abstract] [Full Text] [Related]

  • 20. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
    Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU.
    Exp Neurol; 1997 Jul 06; 146(1):91-103. PubMed ID: 9225742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.